Form 8-K - Current report:
SEC Accession No. 0001193125-24-007021
Filing Date
2024-01-12
Accepted
2024-01-12 06:04:59
Documents
12
Period of Report
2024-01-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d94559d8k.htm   iXBRL 8-K 22779
  Complete submission text file 0001193125-24-007021.txt   143702

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA idya-20240104.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20240104_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20240104_pre.xml EX-101.PRE 11266
6 EXTRACTED XBRL INSTANCE DOCUMENT d94559d8k_htm.xml XML 3366
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38915 | Film No.: 24530513
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)